[go: up one dir, main page]

DE69231811D1 - Uebergangsmetall-Nitridokomplex enthaltendes Radiopharmazeutisches Produkt mit einer Neigung zum Gehirn, Verfahren zu deren Herstellung - Google Patents

Uebergangsmetall-Nitridokomplex enthaltendes Radiopharmazeutisches Produkt mit einer Neigung zum Gehirn, Verfahren zu deren Herstellung

Info

Publication number
DE69231811D1
DE69231811D1 DE69231811T DE69231811T DE69231811D1 DE 69231811 D1 DE69231811 D1 DE 69231811D1 DE 69231811 T DE69231811 T DE 69231811T DE 69231811 T DE69231811 T DE 69231811T DE 69231811 D1 DE69231811 D1 DE 69231811D1
Authority
DE
Germany
Prior art keywords
brain
tendency
preparation
pct
transitional metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69231811T
Other languages
English (en)
Other versions
DE69231811T2 (de
Inventor
Roberto Pasqualini
Emmanuel Bellande
Veronique Comazzi
Jacques Laine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CIS Bio International SA
Original Assignee
CIS Bio International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CIS Bio International SA filed Critical CIS Bio International SA
Publication of DE69231811D1 publication Critical patent/DE69231811D1/de
Application granted granted Critical
Publication of DE69231811T2 publication Critical patent/DE69231811T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69231811T 1991-07-22 1992-07-22 Uebergangsmetall-Nitridokomplex enthaltendes Radiopharmazeutisches Produkt mit einer Neigung zum Gehirn, Verfahren zu deren Herstellung Expired - Fee Related DE69231811T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9109231A FR2679452B1 (fr) 1991-07-22 1991-07-22 Produit radiopharmaceutique ayant notamment un tropisme cerebral, comportant un complexe nitruro d'un metal de transition, et son procede de preparation.
PCT/FR1992/000718 WO1993001839A1 (fr) 1991-07-22 1992-07-22 Produit radiopharmaceutique ayant notamment un tropisme cerebral comportant un complexe nitruro d'un metal de transition, et son procede de preparation

Publications (2)

Publication Number Publication Date
DE69231811D1 true DE69231811D1 (de) 2001-06-07
DE69231811T2 DE69231811T2 (de) 2001-11-22

Family

ID=9415380

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69231811T Expired - Fee Related DE69231811T2 (de) 1991-07-22 1992-07-22 Uebergangsmetall-Nitridokomplex enthaltendes Radiopharmazeutisches Produkt mit einer Neigung zum Gehirn, Verfahren zu deren Herstellung

Country Status (12)

Country Link
US (1) US5496929A (de)
EP (1) EP0596037B1 (de)
JP (1) JPH07500816A (de)
AT (1) ATE200867T1 (de)
AU (1) AU662351B2 (de)
CA (1) CA2113830A1 (de)
DE (1) DE69231811T2 (de)
DK (1) DK0596037T3 (de)
ES (1) ES2157905T3 (de)
FR (1) FR2679452B1 (de)
GR (1) GR3036304T3 (de)
WO (1) WO1993001839A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5821260A (en) * 1992-10-30 1998-10-13 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5750088A (en) * 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5792787A (en) * 1995-06-07 1998-08-11 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
FR2736834B1 (fr) * 1995-07-17 1997-08-29 Cis Bio Int Produits radiopharmaceutiques a tropisme cardiaque comportant un complexe nitruro d'un metal de transition et ayant une clairance myocardique rapide
JP3935218B2 (ja) 1996-12-18 2007-06-20 日本メジフィジックス株式会社 放射性遷移金属窒化物へテロ錯体
ES2315295T3 (es) * 2000-07-28 2009-04-01 Nihon Medi-Physics Co., Ltd. Radiofarmaco para obtencion de imagenes diagnosticas que contiene un heterocomplejo de nitruro de tecnecio-99m.
US8182789B2 (en) 2006-01-20 2012-05-22 Nihon Medi-Physics Co., Ltd. Intermediate compound of technetium nitride complex for radiodiagnostic imaging
EP2426107A1 (de) * 2010-08-05 2012-03-07 Universitat Autònoma De Barcelona Übergangsmetallkonjugierte Radiopharmazeutika als Therapie- und/oder Diagnosemittel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166746B1 (de) * 1983-12-29 1991-04-24 The Commonwealth Of Australia Herstellung von mit 99m tc markierten radioarzneimitteln
US5279811A (en) * 1987-02-18 1994-01-18 The Du Pont Merck Pharmaceutical Company Ester-substituted diaminedithiols and radiolabeled complexes thereof
US5301278A (en) * 1988-04-29 1994-04-05 International Business Machines Corporation Flexible dynamic memory controller
CA2003880C (fr) * 1988-11-25 2002-01-08 Roberto Pasqualini Produit radiopharmaceutique ayant notamment un tropisme cardiaque comportant un complexe nitruro d'un metal de transition, et son procede de preparation
JPH05508162A (ja) * 1990-06-18 1993-11-18 マリンクロッド・メディカル・インコーポレイテッド イソニトリルリガンド含有金属―放射性核種錯化合物
FR2664166A1 (fr) * 1990-07-04 1992-01-10 Cis Bio Int Procede de preparation de complexes nitruro de metaux de transition utilisables comme produits radiopharmaceutiques ou pour la synthese de nouveaux produits radiopharmaceutiques.

Also Published As

Publication number Publication date
WO1993001839A1 (fr) 1993-02-04
GR3036304T3 (en) 2001-10-31
AU2432292A (en) 1993-02-23
DK0596037T3 (da) 2001-08-06
ES2157905T3 (es) 2001-09-01
EP0596037A1 (de) 1994-05-11
US5496929A (en) 1996-03-05
DE69231811T2 (de) 2001-11-22
FR2679452A1 (fr) 1993-01-29
JPH07500816A (ja) 1995-01-26
AU662351B2 (en) 1995-08-31
ATE200867T1 (de) 2001-05-15
FR2679452B1 (fr) 1993-11-12
CA2113830A1 (en) 1993-01-23
EP0596037B1 (de) 2001-05-02

Similar Documents

Publication Publication Date Title
DE69231811D1 (de) Uebergangsmetall-Nitridokomplex enthaltendes Radiopharmazeutisches Produkt mit einer Neigung zum Gehirn, Verfahren zu deren Herstellung
DE59309902D1 (de) Azachinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE132156T1 (de) Latente carbamat-silizium-haftvermittler und verfahren zu deren herstellung und verwendung
ATE79368T1 (de) Herstellung von 5-acylamino-2,4,6-trijodo- oder tribromo-benzoesaeure-derivate.
EP0530505A3 (en) Hydantoin derivatives
ATE186303T1 (de) Galakturonsäure-derivate, verfahren zur ihrer herstellung und ihre verwendung
ATE205837T1 (de) Chinoxaline, verfahren zu ihrer herstellung und ihre verwendung
ZA921369B (en) Novel poly-iodinated compounds, process for their preparation, contrast medium containing them.
GR3031321T3 (en) Isothiourea derivatives as no synthase inhibitors
DK0545983T3 (da) Mellemprodukter for chelateringsmidler med forud fastsat symmetri samt fremgangsmåde til fremstilling heraf
ATE130845T1 (de) Verfahren zur herstellung von 3-amino-2- (het)aroyl-acrylsäurederivaten.
ATE70837T1 (de) Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
DE59309756D1 (de) 4-Iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0141325A3 (de) Rotes Azinpigment
PT80320B (en) Process for the preparation of 2,3-diamino-2,3-didesoxyhexose derivatives
CA2050334A1 (en) Iodinated non-ionic compounds, process for their preparation and contrast materials containing them
DE59209621D1 (de) Verfahren zur Herstellung von Guanin und seiner Alkalimetallsalze
DE3478787D1 (en) Composition for hair-treatment
JPS56110608A (en) Hair rinse agent composition
DE3170942D1 (en) N-phthalidyl-5-fluorouracil derivatives
ATE165341T1 (de) Verfahren zur herstellung c-substituierter diethylentriamine
ATE24718T1 (de) Alkylcycloalkyl-imidazolylmethyl-ketone und verfahren zu ihrer herstellung.
DE59109185D1 (de) Verfahren zur Herstellung von 20-METHYL-5,7-PREGNADIEN-3 DOLLAR g(b),21-DIOL-DERIVATIVEN
DE69209094D1 (de) Verfahren zur herstellung von 2-amino-7-nitrobenzothiazolen
ATE89270T1 (de) Quaternaere ammoniumsalze, verfahren zu deren herstellung und verwendung derselben.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee